Atlas Trials

Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial

Clinical trial NCT04409834 · COMPLETED

Trial details

NCT number
NCT04409834
Sponsor
The TIMI Study Group
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
COVID-19Venous ThromboembolismArterial Thrombosis
Start date
2020-08-05
Primary completion
2022-03-10
Enrollment
390

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.